Integrative Biology of Exercise  by Hawley, John A. et al.
Leading Edge
ReviewIntegrative Biology of Exercise
John A. Hawley,1,2,* Mark Hargreaves,3 Michael J. Joyner,4 and Juleen R. Zierath5,6,*
1Exercise & Nutrition Research Group, School of Exercise Sciences, Australian Catholic University, Fitzroy, Victoria 3065, Australia
2Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Merseyside L3 5UA, UK
3Department of Physiology, The University of Melbourne, Parkville, Victoria 3010, Australia
4Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA
5Department of Molecular Medicine, Karolinska Institutet, von Eulers va¨g 4a, 171 77 Stockholm, Sweden
6The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen,
2200 Copenhagen, Denmark
*Correspondence: john.hawley@acu.edu.au (J.A.H.), juleen.zierath@ki.se (J.R.Z.)
http://dx.doi.org/10.1016/j.cell.2014.10.029Exercise represents a major challenge to whole-body homeostasis provoking widespread pertur-
bations in numerous cells, tissues, and organs that are caused by or are a response to the increased
metabolic activity of contracting skeletal muscles. To meet this challenge, multiple integrated and
often redundant responses operate to blunt the homeostatic threats generated by exercise-
induced increases in muscle energy and oxygen demand. The application of molecular techniques
to exercise biology has provided greater understanding of themultiplicity and complexity of cellular
networks involved in exercise responses, and recent discoveries offer perspectives on the mech-
anisms by which muscle ‘‘communicates’’ with other organs and mediates the beneficial effects
of exercise on health and performance.Introduction
Superior locomotive ability was once essential for human
survival and a fundamental reason that Homo sapiens evolved
and prospered. Physical activity was obligatory for evading
predators and food procurement. Evolutionary theory describes
themechanism of natural selection as ‘‘survival of the fittest,’’ the
underlying supposition being that the ‘‘fit,’’ as opposed to the
‘‘unfit,’’ had a greater likelihood of survival. Modern day humans
run faster, jump higher, and are stronger than at any time in his-
tory. Yet exercise, particularly when undertaken to an individ-
ual’s maximum, is a complex process involving the synchronized
and integrated activation of multiple tissues and organs at the
cellular and systemic level. Though the reductionist approach
of dissecting biological systems into their constituent parts has
been valuable in explaining the basis of many biochemical pro-
cesses, for exercise biologists, this approach has severe limita-
tions: the integrative biology of exercise is extremely complex
and can be neither explained nor predicted by studying the indi-
vidual components of various entities.
Exercise represents a major challenge to whole-body homeo-
stasis, and in an attempt to meet this challenge, myriad acute
and adaptive responses take place at the cellular and systemic
levels that function to minimize these widespread disruptions.
Previous reviews have considered the metabolic responses to
exercise and the cellular mechanisms that underpin skeletal
muscle adaptation to exercise training (Bassel-Duby and Olson,
2006; Coffey and Hawley 2007; Egan and Zierath, 2013; Hop-
peler et al., 2011). Here, we highlight that voluntary, dynamic,
whole-body exercise provokes widespread changes in
numerous cells, tissues, and organs that are caused by or are
a response to the increased metabolic activity of contracting738 Cell 159, November 6, 2014 ª2014 Elsevier Inc.skeletal muscle. To meet this challenge, multiple integrated
and redundant responses operate to blunt the homeostatic
threats generated by the increased energy and O2 demand. In
this ‘‘muscle-centric’’ view of exercise, the systemic (cardiovas-
cular, respiratory, neural, and hormonal) responses are viewed
as ‘‘service functions,’’ supplying the contracting muscles with
fuel and O2 to sustain a given level of activity. The fundamental
premise is that multiscale and redundant responses simulta-
neously operate to blunt the many challenges to whole-body ho-
meostasis caused by the demands of the contracting muscles.
The application of molecular biology techniques to exercise
biology has provided a better understanding of the multiplicity
and complexity of cellular pathways involved in these exercise
responses. Recent discoveries offer perspectives on the role
played by skeletal muscle in numerous homeostatic processes
and on the mechanisms by which muscle ‘‘communicates’’
with other organs such as adipose tissue, liver, pancreas,
bone, and brain.
Why Study Exercise?
There are several broad reasons to study exercise. Hypotheses
generated over the last two decades from comparative physiol-
ogists (Hochachka et al., 1999) and anthropologists (Bramble
and Lieberman, 2004) suggest that the combined traits of supe-
rior endurance capacity and an impressive ability to thermoreg-
ulate permitted ancestral humans from the high plains of East
Africa to succeed as game hunters and thereby obtain high-pro-
tein sources of food that were essential for the emergence of
larger brains and complex cooperative behavior. Human skeletal
muscles, limbs, and the supporting ventilatory, cardiovascular,
and metabolic systems were well suited for upright locomotion,
with economy of movement for bipedal walking and running far
exceeding that of other primates (Bramble and Lieberman,
2004; Brooks, 2012). At this time, lifestyle and energy availability
were inextricably linked to the periodic cycles of feasts and
famines, with certain genes evolving to regulate efficient storage
and utilization of endogenous fuel stores, the so-called ‘‘thrifty
genes’’ (Neel, 1962). Expanding on Neel’s original concept, sur-
vival during feast-famine cycles throughout the hunter-gatherer
period was accompanied by the selection of genes and traits
to support a ‘‘physical activity cycle’’ (Booth et al., 2002; Chak-
ravarthy and Booth, 2004), and under these constraints most
of the present human genome evolved. During modern times,
those alleles and traits that evolved for energy storage and
locomotion are now exposed to an inactive lifestyle and access
to energy-dense foods over an extended lifespan, thereby
increasing the risk of chronic disease. Therefore, the first reason
to study exercise is to provide insight into the pathogenic pro-
cesses underpinning the numerous contemporary physical
inactivity-mediated disorders.
The recent emergence of noncommunicable diseases as ma-
jor killers in industrialized nations (Bauer et al., 2014) and the role
of physical activity in preventing and/or treating these conditions
is a second reason to study exercise. A sedentary life is now so
prevalent that it has become common to refer to exercise as hav-
ing ‘‘healthy benefits’’ even though the exercise-trained state is
the biologically normal condition. It is a lack of exercise that is
abnormal and carries health risks (Booth and Lees, 2006). Phys-
ical inactivity increases the incidence of at least 17 unhealthy
conditions and related chronic diseases (Booth et al., 2000),
whereas a low exercise capacity is an independent predictor of
all-cause mortality (Blair et al., 1996; Myers et al., 2002) and
morbidity (Willis et al., 2012). Yet exercise in both biological
research and as primary preventative therapy continues to be
undervalued and underutilized by the scientific and medical
communities. Consequently, a third reason to study exercise is
to determine the precise mechanisms by which it promotes
whole-body health and to establish molecular links between
specific exercise interventions and disease prevention. Although
the last decade has seen major advances in unraveling the
mechanism(s) by which cellular, molecular, and biochemical
pathways are affected by exercise, the understanding of how
these effects are linked to health benefits is still lacking. In this
context, epidemiological evidence suggests that only half of
the protective effects of exercise can be explained on the basis
of traditional risk factors like reductions in blood pressure (BP)
and blood lipids (Joyner and Green, 2009).
A fourth reason to study exercise is to understand the capacity
of various mammalian species to function in extreme environ-
ments and to test hypotheses about physiological regulation
under such conditions. In this context, humans are competent
athletes, but our capacity for locomotion is paltry compared
with that of other species that are more powerful and faster
and possess greater endurance. With respect to speed, the
cheetah (Acinonyx jubatus) reigns supreme among terrestrial
mammals, achieving maximum velocities of 113 km/hr (Sharp,
1997), making the world’s fastest human (with a top speed of
48 km/hr) seem rather pedestrian. The pronghorn antelope (Anti-
locapra Americana) can sustain speeds of >80 km/hr for 4–5 km,and the Greyhound and sled dog are similarly capable of extraor-
dinary bursts of speed (Poole and Erickson, 2011). Notwith-
standing such comparisons, research into the ‘‘limits’’ of athletic
capacity provides insight into the roles of various organ systems
involved in maximizing human performance (Joyner and Coyle,
2008). Such enquiry is not new. In 1925, Nobel Laureate A.V.
Hill published a paper on the physiological basis of athletic re-
cords (Hill, 1925) and was the first to describe the concept of
an individual’s maximum oxygen uptake (VO2max) as an index
of the highest energy demand that can be met aerobically while
exercising. Hill proposed that an individual’s VO2max was the sin-
gle best measure of cardio-respiratory performance and could
be used for quantifying the adaptation of many organ systems
to physical activity or inactivity (Bassett, 2002). Perhaps fittingly,
the test for VO2max for the assessment of athletic potential orig-
inally proposed by Hill is now recognized as a better predictor of
mortality than any other established risk factor or biomarker for
cardiovascular disease (Myers et al., 2002). Clearly the biology
underlying maximal exercise performance confers advantages
beyond the athletic arena!
Voluntary Exercise: More Than Muscle Contraction
What We Mean When We Talk about Exercise
Exercise is the voluntary activation of skeletal muscle for recre-
ational, sporting, or occupational activities. The distinction be-
tween voluntary, whole-body in vivo responses to exercise
versus those evoked by other experimental models is important.
Ex vivo electrical stimulation of an isolated skeletal muscle, for
instance, evokes an action potential and ‘‘contraction’’ and trig-
gers intracellular pathways with putative roles in training adapta-
tion (Fitts and Holloszy, 1978). However, whole-body, voluntary
exercise induces a range of additional physiological responses
that are critical for muscle performance (and movement).
Accordingly, many effects observed in animals and isolated sys-
tems frequently differ from those seen in humans in vivo, and
care should be taken when extrapolating responses from one
set of conditions or a given experimental model to another
(Schlegel and Stainier, 2007).
Voluntary exercise encompasses many elements beyond
simple muscle contraction. Volitional effort generated in the mo-
tor cortex of the brain drives the spinal cord to recruit motor
units, resulting in specific movement patterns. In parallel with
neural signals to skeletal muscle, there are also powerful neural
feedforward signals to the cardiovascular, respiratory, and
metabolic and hormonal systems, along with neural feedback
from the contracting skeletal muscles, that generally permit
metabolic demands to be met with limited disruption of homeo-
stasis (Figure 1).
Numerous issues relating to the speed, force, duration, and in-
tensity of muscle contractions, along with the total muscle mass
engaged in the activity, are important for a complete understand-
ing of the physiological responses to exercise. An isometric or
static contraction of high force but short duration compresses
blood vessels in the contracting musculature and limits blood
flow and O2 delivery to those muscles while simultaneously
increasing BP. In contrast, during sustained rhythmic exercise
like cycling or running, the contraction times are short, there is
little disruption of muscle blood flow, and perturbations in BPCell 159, November 6, 2014 ª2014 Elsevier Inc. 739
Figure 1. The Physiological Responses to
Voluntary, Dynamic Exercise
Multiple organ systems are affected by exercise,
initiating diverse homeostatic responses.are minimized. The muscle mass engaged in exercise is critical,
as it determines both the absolute O2 flux and total fuel require-
ments. For most aerobic-based activities, such as running or
cycling, activemusclemass amounts to15 kg in a 70 kg athlete
(Coyle et al., 1991), although for rowing and cross-country skiing
(for which the athlete is substantially taller and heavier), this is
markedly higher (Hagerman 1984). The nomenclature relating
to the quantification of exercise intensity is also relevant because
the prevailing work rate exerts a major role in determining the
overall physiological responses to exercise. For exercise lasting
>5 min, intensity is typically expressed as a percentage of an in-
dividual’s VO2max. Low-, moderate-, and high-intensity exercise
correspond to <45%, 45%–75%, and >75% of individual
VO2max, respectively.
Skeletal Muscle Energy Metabolism
ATP is required to fuel the cellular processes supporting muscle
contraction. These include the maintenance of sarcolemmal
excitability (Na+/K+ ATPase), reuptake of Ca2+ into the sarco-
plasmic reticulum (Ca2+ ATPase), and force generation via
actin-myosin cross-bridge cycling (myosin ATPase). Intramus-
cular [ATP] is remarkably well maintained over a wide range of
exercise intensities and durations, and while [ATP] declines
under certain exercise and/or environmental conditions, the
magnitude of change is small when considered against the total
turnover of ATP within active myocytes. During sprint exercise,
ATP turnover can increase 100-fold above rest (Gaitanos et al.,
1993; Parolin et al., 1999), a range of metabolic activity
exceeding that in all other tissues and one that poses a major
energetic challenge to the contracting myofibers. Given that
intramuscular [ATP] is relatively small, metabolic pathways
responsible for ATP resynthesis are rapidly activated. During
short-term (30–60 s) maximal exercise, this is achieved primar-
ily through substrate-level phosphorylation via the breakdown of
creatine phosphate and during the conversion of glucose units,
derived almost entirely from intramuscular glycogen, to lactate
(Gaitanos et al., 1993; Parolin et al., 1999). The mobilization of
extramuscular substrates is also critical to maintain skeletal
muscle metabolism during prolonged exercise (van Loon et al.,
2005; Wasserman, 2009). Thus, the liver increases the release740 Cell 159, November 6, 2014 ª2014 Elsevier Inc.of glucose into the circulation (initially
derived from glycogenolysis and later
from gluconeogenesis), and the adipo-
cyte increases the hydrolysis of its triglyc-
eride stores and the release of long-chain
nonesterified fatty acids into the blood-
stream.
The relative contribution of carbohy-
drate and lipid to oxidative metabolism
is determined primarily by the prevailing
exercise intensity (Romijn et al., 1993)
and is influenced by prior diet, training
status, sex, and environmental condi-tions (Jeukendrup 2003). The contribution from the oxidation of
carbohydrate-based fuels rises with increasing exercise inten-
sity, with a concomitant reduction in lipid oxidation. Conversely,
during prolonged exercise at a fixed level of moderate intensity,
rates of carbohydrate oxidation decline as lipolysis and fat
oxidation increase. The regulation of fuel mobilization and utiliza-
tion involves a combination of local factors such as sarcoplasmic
[Ca2+], intramuscular levels of ATP breakdown products (ADP,
AMP, IMP, Pi), and muscle temperature and intramuscular sub-
strate availability, as well as systemic factors such as the plasma
level of key hormones (epinephrine, insulin, and glucagon) and
circulating metabolites (Hawley et al., 2006). These factors are
not only involved in mediating the acute response to exercise,
but also activate signaling pathways critical for many of the
chronic adaptations to regular exercise training. Recent reviews
have summarized the various cellular and molecular factors
involved in the regulation of skeletal muscle carbohydrate (Jen-
sen and Richter, 2012; Richter and Hargreaves, 2013) and lipid
(Jeppesen and Kiens, 2012) metabolism during exercise, as
well as the interactions between them (Spriet, 2014).
Oxygen Transport System
At rest, whole-body O2 consumption in healthy, young, adult
humans averages about 3.5 ml/kg/min, with 20%–25% of
this used by resting skeletal muscle. Thus, for a 70 kg person,
resting O2 consumption is 250 ml/min, with 50 ml/min taken
up by skeletal muscle. In lean, healthy, untrained adults, VO2max
is typically 10–15 times resting values. In elite endurance-trained
athletes, VO2 max values can exceed 85 ml/kg/min (Saltin and
A˚strand, 1967). Though O2 fluxes in humans are high, they are
marginal compared to values achieved by elite racehorses with
VO2max values of 110 l/min, equating to 220 ml/kg/min (Poole
and Erickson, 2011).
VO2max is determined by the combined capacities of the cen-
tral nervous system to recruit motor units, the pulmonary and
cardiovascular systems to deliver O2 to contracting skeletal
muscles, and the ability of those muscles to consume O2 in the
oxidative, metabolic pathways. Associated with large increases
in O2 consumption during maximal exercise in humans are peak
values for cardiac output (Q) and ventilation of 40 and 200 l/min,
Figure 2. Complex and Redundant Physio-
logical Control Mechanisms during Volun-
tary, Dynamic Exercise
Motor cortical drive leads to skeletal muscle
contraction, as well as parallel activation (‘‘central
command’’) of key neuro-endocrine responses,
fuel mobilization, and support systems that in-
crease oxygen and substrate delivery to con-
tracting skeletal muscle. The integrated response
is fine-tuned by afferent feedback, involving me-
chano- and chemo-sensitive type III and IV affer-
ents in active skeletal muscle, but also by critical
sensors that monitor various parameters,
including mean arterial blood pressure (MAP),
blood glucose concentration, oxygen and carbon
dioxide levels, body temperature, and blood
volume.representing 8- and 20-fold increases, respectively, above rest.
In addition, blood flow to active skeletal muscle can increase
100 times above basal levels, accounting for up to 80%–90%
of Q. Notably, there is only a modest (20%) increase in mean
arterial blood pressure (MAP), whereas values for arterial PO2,
PCO2, and pH remain essentially identical to rest until maximal
exercise intensities are reached.
The cardiovascular adjustments to exercise require an intact
autonomic nervous system and are driven by three signals: (1)
feedforward ‘‘central command’’ related to motor output, which
activate selected areas in the brainstem cardiovascular (and res-
piratory) centers to stimulate increases in heart rate (HR), BP,
and ventilation; (2) afferent feedback from thinly myelinated
and unmyelinated type III and IV afferents in contracting muscles
that increase sympathetic activation; and (3) baroreceptors in
the carotid sinus and aortic arch that provide feedback on BP
to the brainstem cardiovascular centers. The HR response to ex-
ercise is driven primarily by central command-mediated vagal
withdrawal and activation of sympathetic outflow to the heart.
Both factors also augment cardiac stroke volume, and the action
of the so-called ‘‘muscle pump’’ ensures that venous return from
the active muscle vasculature maintains diastolic filling and
stroke volume (SV). The central motor drive and central com-
mand are subject to ‘‘fine-tuning’’ via feedback signals that
monitor substrate levels, MAP, blood gases and pH, fluid
status, and body temperature despite the marked ho-
meostatic challenges associated with high-intensity exercise
(Figure 2).
The primary mechanism responsible for skeletal muscle hy-
peremia during exercise is vasodilation in the active skeletal
muscle, most notably in the small arterioles. Mechanical, neu-
ral, and humoral factors, including those released from con-
tracting skeletal muscle, have been implicated in this response.
Because the rise in muscle blood flow is closely coupled to
metabolic rate, vasodilating signal(s) released from contracting
skeletal muscles roughly in proportion to their O2 demand
is(are) responsible (Hellsten et al., 2012). Candidate dilator sub-
stances and mechanisms include inward rectifying K+ chan-
nels, adenosine, ATP from various sources, products of skeletal
muscle metabolism, and reactive O2 species. However, no sin-
gle substance can fully account for the increases in muscleblood flow, and the molecular identity of one or more of these
signals is unknown.
Blood flow is redistributed away from the kidney, liver, other
visceral organs, and inactive muscle via vasoconstriction in
these vascular beds, secondary to increased sympathetic activ-
ity during exercise. This permits a higher fraction of Q to be deliv-
ered to active skeletal muscle and partially offsets the fall in total
peripheral resistance as a result of skeletal muscle vasodilation.
Blood flow to the central nervous system remains either un-
changed or increases slightly, and coronary blood flow in-
creases. Because evaporation of sweat is the major mechanism
for dissipation of heat during exercise, especially at higher envi-
ronmental temperatures, there is an increase in skin blood flow
and sweating-induced fluid loss with exercise (Gonza´lez-Alonso
et al., 2008). With increased exercise intensity, the skin becomes
a target for vasoconstriction as skeletal muscle blood flow in-
creases despite increased metabolic heat production. To main-
tain MAP, skeletal muscle takes priority over skin blood flow. As
exercise approaches VO2max, the finite cardiac pumping capac-
ity means that active skeletal muscle is also subject to vasocon-
striction (Calbet et al., 2004). With increased environmental
stress, the combination of progressive hyperthermia and dehy-
dration further challenges the cardiovascular system during pro-
longed, strenuous exercise (Gonza´lez-Alonso et al., 2008).
The critical functions of the pulmonary system are to maintain
arterial oxygenation and to facilitate the removal of CO2
produced during oxidative metabolism. This is achieved by
increased ventilation in proportion to exercise intensity, and arte-
rial PO2 and PCO2 are generally maintained at resting levels until
heavy exercise. The factors responsible for the marked increase
in ventilation include descending central command in parallel
with motor cortical activation of skeletal muscle that stimulates
the brainstem respiratory centers and feedback stimulation
from type III and IV afferents (Dempsey et al., 2014). In most
healthy individuals exercising at sea level, arterial oxyhemo-
globin saturation (SaO2) is well maintained. However, in some
highly trained endurance athletes, high-intensity exercise results
in a significant drop in SaO2 that impairs O2 delivery to contract-
ing skeletal muscle and results in impaired exercise capacity
(Amann et al., 2006). Another threat to locomotor muscle O2 de-
livery and performance during high-intensity exercise is reflexCell 159, November 6, 2014 ª2014 Elsevier Inc. 741
sympathetic vasoconstriction of the limb skeletal muscle vascu-
lature, secondary to activation of type III and IV afferents in
respiratory muscles (Dempsey et al., 2002). Increases in respira-
tory muscle work during heavy exercise result in increased
metabolite accumulation and activation of these afferents. This
reflex serves to direct a greater proportion of the limited Q to
the respiratory muscles but at the expense of the locomotor
muscles and exercise performance.
The acute cardiovascular adaptations to both dynamic and
isometric exercise lead to patterns of long-term remodeling
and adaptations that increase VO2max and minimize disruptions
in whole-body homeostasis. The autonomic and sensory feed-
back systems described previously are subject to chronic reset-
ting so that, during dynamic exercise, somewhat lower BPs are
tolerated, thus permitting greater increases in skeletal muscle
blood flow. This is accompanied by cellular changes in the brain-
stem cardiovascular center that tend to be pro-vagal and sym-
pathoinhibitory. These changes partly explain why exercise at
any given submaximal work rate after training is accompanied
by a lower HR and BP. They also contribute to the chronic BP
lowering effects of exercise in general. Adaptations to resistance
training are less well characterized. However, during maximal
weight lifting, BP can exceed 480/350 mmHg (MacDougall
et al., 1985), consistent with the idea that compression of the
blood vessels in the contracting skeletal muscles evokes re-
sponses designed to overcome ‘‘under perfusion’’ by substan-
tially increasing BP.
With dynamic exercise, there is considerable remodeling of
the vascular system, especially in the skeletal muscles subjected
to training, including an increase in the diameter of large con-
ducting vessels like the femoral artery for leg exercise (Green
et al., 2012). There is also an increase in the number of arterioles
and increased capillary density in the trained musculature. This
structural remodeling is driven by a complex and redundant
sequence of events that includes NO, prostaglandins, and
vascular endothelial growth factor (VEGF) signaling pathways
(Hoier and Hellsten, 2014). The time course of remodeling also
varies by blood vessel size. Early in exercise training, there is a
marked increase in nitric oxide synthase (NOS) expression in
the large conducting vessels in response to increased shear
stress. However, as the caliber of the vessel increases with
training, the shear stress normalizes andNOSexpression returns
to baseline values. Though many of these adaptations are
restricted to the vascular beds of the working muscle, improved
endothelial function appears to be a whole-body response to
exercise training.
Dynamic exercise training is associated with an increase in
cardiac chamber size, but not wall thickness, that facilitates
the increase in SV caused by this mode of training. Endurance
training promotes volume hypertrophy, whereas resistance
training does not cause major changes in the thickness of
cardiac muscle. The stimulus for cardiac volume hypertrophy
with dynamic exercise training is stretch of the ventricle caused
by the increased venous return from the periphery. This stretch
is facilitated by training-induced increases in blood volume
and catecholamine concentrations. The cellular mechanisms
responsible for cardiac hypertrophy with exercise training
involve activation of a number of pathways, including the insu-742 Cell 159, November 6, 2014 ª2014 Elsevier Inc.lin-like growth factor 1 (IGF-1)-phosphatidylinositide 3-kinase
(PI3K)-Akt/protein kinase B axis (Ellison et al., 2012), in particular
PI3K (p110a). Downstream of Akt, exercise-induced cardiomyo-
cyte hypertrophy and proliferation appears to be associated with
reduced C/EBPb expression and a concomitant increase in
CITED4 expression (Bostro¨m et al., 2010). Cardiac hypertrophy
also involves de novo cardiomyocyte formation by activation of
both circulating and tissue-specific cardiac progenitor cells.
In highly motivated young, healthy individuals, VO2max does
not appear to be limited by muscle mitochondrial oxidative
capacity (Boushel et al., 2011). Rather, O2 delivery to skeletal
muscle is rate limiting, and although this is determined by both
convective and diffusive mechanisms, central cardiovascular
function and the ability to increase active skeletal muscle blood
flow appear to be critical (Gonza´lez-Alonso and Calbet, 2003).
However, muscle mitochondrial oxidative capacity does appear
to be an important determinant of endurance exercise perfor-
mance (Joyner and Coyle, 2008). Thus, treadmill running time
at submaximal exercise intensity is used as a physiological
correlate of transgenic interventions that impact muscle oxida-
tive capacity (Potthoff et al., 2007; Wang et al., 2004).
Skeletal Muscle Matters
Skeletal Muscle Fiber Type and Adaptation Plasticity
The application of surgical techniques to exercise biochemistry
in the 1960s (Bergstro¨m and Hultman 1966) made it possible
to obtain small (100–150 mg) samples of human skeletal muscle
for histological and biochemical studies to identify specific
morphological, contractile, and metabolic properties. Using
these approaches, different fiber types have been identified
along with their contractile characteristics, and these have
been related to functional and metabolic properties of skeletal
muscle during exercise (Saltin et al., 1977). Themetabolic poten-
tial of muscle has also been evaluated by determining different
substrate and enzyme activities. Comprehensive discussion of
skeletal muscle fiber types and the gene programs responsible
for fiber-specific properties are beyond the scope of this Review
and have been summarized elsewhere (Bassel-Duby and Olson
2006; Saltin et al., 1977; Schiaffino and Reggiani 1996; Zierath
andHawley 2004). However, a brief overview of the classification
of human muscle fiber types and their metabolic potential is
warranted.
Histologically, skeletal muscle appears uniform but is
comprised of myofibers that are heterogeneous with respect to
size, metabolism, and contractile function. On the basis of spe-
cific myosin heavy-chain isoform expression, myofibers can be
classified into type I, type IIa, type IId/x, and type IIb fibers,
with types I and IIa exhibiting high oxidative potential and capil-
lary supply and with types IIx and IIb fiber being primarily glyco-
lytic (Pette and Staron 2000; Saltin et al., 1977; Schiaffino and
Reggiani 1996). Type I myofibers are typically referred to as
‘‘slow-twitch fibers’’ because they exert slow contraction time
to peak tension, owing to the ATPase activity associated with
the type I myosin, whereas type II fibers are termed ‘fast-twitch’
myofibers and have quicker contraction time but a rapid fatigue
profile (Bassel-Duby and Olson 2006; Saltin et al., 1977). With
endurance training, the enhancement of the oxidative potential
of type IIx and IIb fibers is markedly increased, resulting in a
Figure 3. Repeated Transient Bursts in Messenger Ribonucleic Acid
Precede Increases in Transcriptional and Mitochondrial Proteins in
Response to Short-Term Training
Subjects (n = 9) completed seven sessions of high-intensity interval training
during a 2 week intervention. Skeletal muscle biopsies from the vastus lateralis
were obtained 4 and 24 hr after the first, third, fifth, and seventh training
session. PGC-1a, peroxisome-proliferator-activated receptor g coactivator a;
CS, citrate synthase. Data are redrawn from Perry et al. (2010).potential for oxidation that markedly surpasses the aerobic ca-
pacity of type I fibers of untrained individuals (Saltin et al.,
1977). Indeed, the absolute level for the activities of both oxida-
tive and glycolytic enzymes in all fiber types in humans is large
enough to accommodate a substantial range of aerobic and
anaerobic metabolism.
Whether endurance- or resistance-based exercise training in
humans can result in fiber type ‘‘reprogramming’’ remains
open to debate. Certainly endurance training induces changes
in the metabolic properties of skeletal muscle by conferring an
increased oxidative profile to the trained myofibers (Saltin
et al., 1977). Such effects are likely to involve a plethora of
signaling cascades and transcription factors including, but not
limited to, calcium signaling pathways involving calcineurin,
calcium-calmodulin-dependent kinase, and the transcriptional
cofactors peroxisome proliferator-activated receptor g coactiva-
tor 1a (PGC-1a) and PPARd (Olson and Williams 2000; Lin et al.,
2002; Wang et al., 2004; Wu et al., 2002). However, the specific
transcriptional factors directly involved in the control of the mus-
cle phenotype and fiber-specific contractile properties remain to
be fully characterized.
Human skeletal muscle displays remarkable plasticity, with
the capacity to alter both the type and amount of protein in
response to disruptions in cellular homeostasis induced by the
habitual level of contractile activity, the prevailing substrate
availability, and environmental conditions (Hawley et al., 2011;
Zierath and Hawley 2004). Though this phenomenon of ‘‘adapta-
tion plasticity’’ is common to all vertebrates, a large variation in
the degree of adaptability between humans is evident. This partly
explains the large interindividual responses to standardized
exercise training interventions and the striking differences in per-
formance between individuals (Bouchard et al., 2011). The func-
tional consequences of adaptation plasticity are specific to the
mode of exercise and are influenced by the volume, intensity,
and frequency of the contractile stimuli along with the half-life
of specific exercise-induced proteins (Hawley 2002). Prolongedendurance-based exercise training elicits changes that increase
the mitochondrial protein content and respiratory capacity of the
trained myofibers. These adaptations underpin the altered pat-
terns of substrate oxidation during submaximal exercise (from
carbohydrate- to fat-based fuels) that result in less lactate pro-
duction at a given submaximal power output or speed (Holloszy
1967). In contrast, strength and resistance-based training stimu-
lates the myofibrillar proteins responsible for muscle hypertro-
phy, culminating in increases in maximal contractile force output
(Phillips 2014) without substantial changes in fuel use during
exercise. Concomitant with the vastly different functional
outcomes induced by these diverse exercise modes, the ge-
netic and molecular machinery affecting these adaptations are
distinct.
Adaptations to Exercise Training: The Cumulative Effect
of Repeated Exercise Bouts
The conversion of various chemical, electrical, and mechanical
signals generated duringmuscle contraction tomolecular events
promoting physiological responses and subsequent adaptations
involves a cascade of events resulting in activation and/or
repression of specific signaling pathways regulating exercise-
induced gene expression and protein synthesis/degradation.
These pathways are numerous and have been reviewed else-
where (Bassel-Duby and Olson 2006; Coffey and Hawley 2007;
Egan and Zierath, 2013; Hood et al., 2006). Potential signals dur-
ing contractile activity include, but are not limited to, increased
sarcoplasmic [Ca2+], increased AMP and/or an increased ADP/
ATP ratio, reduced creatine phosphate and glycogen levels,
increased fatty acid and ROS levels, acidosis, and altered redox
state, including NAD/NADH, and hyperthermia (Hawley et al.,
2006). Redundancy and compensatory regulation are key
characteristics of biological systems that act to preserve physi-
ological responses and adaptations to a variety of ‘‘threats’’ to
cellular homeostasis. Indeed, some gene deletions or mutations
have little effect on metabolic adaptation, highlighting the poten-
tial caveats involved in utilizing transgenic or knockout models to
examinemechanisms of muscle adaptation (McGee et al., 2014).
Key signalingpathways involveCa2+/calmodulin-dependent ki-
nases (CaMK), calcineurin,AMP-activatedprotein kinase (AMPK),
mitogen-activated protein kinases (ERK1/2, p38 MAPK), and
mammalian target of rapamycin (mTOR). The targets of these
signaling pathways include many transcription factors, coactiva-
tors, and repressors. Exercise increases activation of CaMKII
(Rose and Hargreaves, 2003), AMPK (Winder and Hardie 1996;
Fujii et al., 2000), andMAPKs (Widegrenet al., 1998).Aspreviously
noted, contraction-induced alterations in intracellular [Ca2+] are
linked to distinctive programs of gene expression that establish
phenotypic diversity among skeletal myofibers (Chin, 2005; Tavi
and Westerblad, 2011). In addition, activation of AMPK by exer-
cise-induced alterations in muscle energy status increases
gene transcription in skeletal muscle (McGee and Hargreaves,
2010).
Adaptations to exercise training result from the cumulative ef-
fect of transient increases in mRNA transcripts that encode for
various proteins after each successive exercise bout. These
repeated bursts in mRNA expression appear to be essential to
drive the intracellular adaptive response to exercise training
(Neufer and Dohm 1993; Perry et al., 2010) (Figure 3). The timingCell 159, November 6, 2014 ª2014 Elsevier Inc. 743
Figure 4. Schematic of the Major Signaling Pathways Involved in
the Control of Skeletal Muscle Hypertrophy and Mitochondrial
Biogenesis
Multiple primary signals, including, but not limited to, mechanical stretch,
calcium, pH, redox state, hypoxia, and muscle energy status, are altered with
voluntary dynamic exercise. Following initiation of one or more of these pri-
mary signals, additional kinases/phosphatases are activated to mediate a
specific exercise-induced signal. In mammalian cells, numerous signaling
cascades exist. These pathways are regulated at multiple sites, with sub-
stantial crosstalk between pathways producing a highly sensitive, complex
transduction network.and responsiveness of individual mRNA species to different
types of contractile activity is variable, but peak induction for
both ‘‘metabolic’’ and ‘‘myogenic’’ genes generally occur 4–
8 hr after an exercise bout, with mRNA levels returning to pre-ex-
ercise levels within 24 hr (Yang et al., 2005). Another level of
regulation of mRNA and protein abundance by exercise involves
alterations in DNA methylation status (Barre`s et al., 2012), his-
tone modifications (McGee and Hargreaves, 2011), and micro-
RNA expression (Zacharewicz et al., 2013). Ultimately the ability
of a given muscle cell to alter the type and quantity of protein is a
function of its half-life. Proteins that turn over rapidly and have
high rates of synthesis are capable of attaining a new steady-
state level faster than those that turn over slowly during adapta-
tion to contractile and other stimuli.
Mitochondrial Biogenesis and Endurance Training
Adaptation
Mitochondrial biogenesis requires the coordination of multiple
cellular events, including transcription of two genomes, synthe-744 Cell 159, November 6, 2014 ª2014 Elsevier Inc.sis of lipids and proteins, and the stoichiometric assembly of
multisubunit protein complexes into a functional respiratory
chain (Hood et al., 2006). Impairments at any step can lead to
defective electron transport, failure of ATP production, and an
inability to maintain energy homeostasis. Since the seminal
work of Holloszy (1967), who discovered that muscles of tread-
mill-trained rats exhibited higher levels of mitochondrial proteins
than those of untrained animals, major breakthroughs in unravel-
ing the cellular events controlling skeletal muscle mitochondrial
biogenesis have occurred. Several transcription factors that
regulate the expression of the nuclear genes encoding mito-
chondrial proteins were discovered (Scarpulla 2006). These
include nuclear respiratory factors 1 and 2 (NRF-1, NRF-2) that
bind to the promoters and activate transcription of genes that
encodemitochondrial respiratory chain proteins (Kelly and Scar-
pulla 2004). NRF-1 also activates expression of the nuclear
gene that encodes mitochondrial transcription factor A (TFAM),
which moves to the mitochondria and regulates transcription
of the mitochondrial DNA (i.e., the mitochondrial genome).
Because not all promoters of genes transcribing mitochondrial
proteins have NRF-1-binding sites, other transcription factors
are involved in contractile-modulated mitochondrial biogenesis,
including the estrogen-receptor-related receptors (ERR) a and
d and the peroxisome proliferator-activated receptor coactiva-
tors (PPARs), which regulate expression of the mitochondrial
fatty acid oxidative enzymes (Kelly and Scarpulla, 2004; Scar-
pulla, 2006).
Another major breakthrough in unraveling the cellular events
that promote mitochondrial biogenesis was the discovery of
PGC-1a, an inducible coactivator that regulates the coordinated
expression of mitochondrial proteins encoded in the nuclear and
mitochondrial genomes (Lin et al., 2005). A critical feature of the
PGC-1 coactivators is that they are highly versatile and interact
with many different transcription factors to activate distinct bio-
logical programs in different tissues (Lin et al., 2005). In skeletal
muscle, PGC-1a has emerged as a key regulator of mitochon-
drial biogenesis that responds to neuromuscular input and the
prevailing contractile activity. A single bout of endurance exer-
cise induces a rapid and sustained increase in PGC-1a gene
and protein in skeletal muscle (Mathai et al., 2008), whereas
muscle-specific overexpression of PGC-1a results in a large in-
crease in functional mitochondria (Lin et al., 2002), improve-
ments in whole-body VO2max, a shift from carbohydrate to fat
fuels during submaximal exercise, and improved endurance per-
formance (Calvo et al., 2008). Gain-of-function studies reveal
that expression of PGC-1a at or near physiological levels leads
to activation of genetic programs characteristic of slow-twitch
muscle fibers (Lin et al., 2002), with the muscles of these trans-
genic mice resistant to contraction-induced fatigue. Loss of
function studies challenge the absolute requirement of PGC-1a
for exercise training-induced changes in muscle mitochondrial
biogenesis, angiogenesis, and fiber type changes (Geng et al.,
2010; Rowe et al., 2012). On balance, current observations place
PGC-1a as a central player in orchestratingmany of the oxidative
adaptations to exercise.
AMPK and p38 MAPK are two important signaling cascades
that converge upon the regulation of PGC-1a and consequently
the regulation of mitochondrial biogenesis (Figure 4). AMPK
induces mitochondrial biogenesis partly by directly phosphory-
lating and activating PGC-1a (Ja¨ger et al., 2007), but also by
phosphorylating the transcriptional repressor HDAC5, which
relieves inhibition of the transcription factor myocyte enhancer
factor 2 (MEF2), a known regulator of PGC-1a (McGee and Har-
greaves, 2010). Of note, MEF2 activation is associated with
increased muscle oxidative capacity and running endurance
(Potthoff et al., 2007). p38 MAPK phosphorylates and activates
PGC-1a (Puigserver et al., 2001) and also increases PGC-1a
expression by phosphorylating the transcription factor ATF-2,
which in turn increases PGC-1a protein abundance by binding
to and activating the CREB site on the PGC-1a promoter (Aki-
moto et al., 2005). The tumor suppressor protein p53, presum-
ably activated by AMPK and/or p38 MAPK, is emerging as
another transcription factor involved in exercise-induced mito-
chondrial biogenesis in skeletal muscle. p53 knockout mice
display reduced endurance exercise capacity compared with
wild-type mice, along with reduced subsarcolemmal and inter-
myofibrillar mitochondrial content and PGC-1a expression.
p53 may regulate exercise-induced mitochondrial biogenesis
through interactions with TFAM in the mitochondria, where it
functions to co-ordinate regulation of the mitochondrial genome
(Bartlett et al., 2014).
Muscle Hypertrophy and Myogenic Pathways
Strength training increases muscle fiber size (hypertrophy) and
maximal tension output. These adaptations are attained by pos-
itive muscle protein balance and satellite cell addition to pre-ex-
isting fibers. Positive muscle protein balance occurs when the
rate of newmuscle protein synthesis exceeds that of breakdown.
Although resistance exercise and postprandial hyper-aminoaci-
demia both stimulate muscle protein synthesis, it is through the
synergistic effects of these stimuli that a net gain in muscle pro-
tein occurs and fiber hypertrophy takes place (Phillips 2014).
Activation of mTOR appears to be important for contraction-
induced increases in muscle protein synthesis (Drummond
et al., 2009). Once activated, mTOR exists as two distinct
complexes, mTOR complex 1 (TORC1) and mTOR complex 2
(TORC2). TORC1 is characterized by the presence of regulato-
ry-associated protein of mTOR (RAPTOR), whereas TORC2
binds rapamycin-insensitive companion of mTOR (RICTOR).
These two protein complexes sense diverse signals and produce
amultitude of responses, including mRNA translation, ribosomal
biogenesis, and nutrient metabolism (Coffey and Hawley 2007;
Egerman and Glass, 2014). IGF-1 has long been considered a
key upstream regulator of mTOR. Signaling activated by IGF-1
positively regulates skeletal muscle mass via induction of protein
synthesis downstream of protein kinase B/Akt and the mTOR
pathway (Bodine et al., 2001). IGF-1 transmits signaling along
the PI3K/Akt pathway (Figure 4), resulting in the parallel activa-
tion of the mTOR pathway, producing a multitude of responses,
including mRNA translation, ribosomal biogenesis, and nutrient
metabolism (Coffey and Hawley 2007). Growth-factor-indepen-
dent, mechanosensitive activation of mTOR also contributes to
muscle protein synthesis (Philp et al., 2011).
The most well-defined effectors of mTOR signaling are pro-
teins implicated in translational control: ribosomal protein S6 ki-
nase (p70S6K) and eukaryotic initiation factor 4E-binding protein
(4E-BP1). Indeed, after activation by Akt, TORC1 controls pro-tein synthesis by phosphorylating p70S6 kinase 1 and the 4E-
BP1, and the TORC2 multiprotein complex contributes to the
prolonged activation of Akt. Phosphorylation of p70S6K and
subsequent activation of ribosomal protein S6 enhances transla-
tion of mRNAs, encoding elongation factors and ribosomal
proteins and thereby increasing translational capacity. p70S6K
plays a fundamental role in skeletal muscle hypertrophy (Liu
et al., 2002). A single bout of resistance exercise in humans leads
to increases in p70S6K phosphorylation, which is correlated with
the chronic increase in muscle mass and strength observed after
chronic resistance training. Thus, the acute responses to exer-
cise, including dynamic changes in muscle protein turnover
and the early activation of signaling proteins, may act as surro-
gates of long-term phenotypic changes in muscle mass and
strength.
PGC-1a4, a transcript from the PGC-1a gene, is abundantly
expressed in skeletal muscle and appears to play a role in the
adaptive response to exercise, particularly in the setting of resis-
tance training (Ruas et al., 2012). This protein does not appear to
regulate the same set of oxidative genes induced by PGC-1a
but, rather, activates the expression of IGF-1 while concomi-
tantly suppressing myostatin (an inhibitor of muscle cell differen-
tiation and growth) pathways. After training consisting of either
endurance exercise, resistance exercise, or a combination of
both endurance and resistance exercise, increases in PGC-
1a4 were confined to resistance-only and combined exercise
training programs, with no changes in this transcript after endur-
ance-only training (Ruas et al., 2012). Though these results are
notable, the proposal that skeletal muscle hypertrophy following
resistance exercise is mediated through PGC-1a4 remains a
matter of debate.
Skeletal muscle from endurance- and strength-trained individ-
uals represents diverse adaptive states (Figure 4). Thus, it
is hardly surprisingly that simultaneously training for both
endurance and strength results in a compromised adaptation
compared with training for either exercise modality alone (Hick-
son 1980), a phenomemon known as the ‘‘interference effect.’’
These observations made more than 30 years ago (Hickson
1980) raised the possibility that the genetic and molecular
mechanisms of adaptation induced by endurance and resis-
tance training are distinct, with each mode of exercise activating
and/or repressing specific subsets of genes and cellular
signaling pathways. Preliminary evidence for selective activation
and/or downregulation of the AMPK-PGC-1a or Akt-mTOR
signaling pathways was reported in rodent skeletal muscle in
response to either low-frequency (to mimic endurance training)
or high-frequency (to mimic resistance training) electrical stimu-
lation in vitro (Atherton et al., 2005). However, in well-trained hu-
mans, little evidence exists for an AMPK-Akt ‘‘master switch.’’
Using highly trained athletes with a history of either endurance
or strength training who performed both an acute bout of
exercise in their specialized discipline and then ‘‘crossed over’’
and undertook a bout of unfamiliar exercise, a high degree of
‘‘response plasticity’’ is conserved at opposite ends of the
endurance-hypertrophic adaptation continuum (Coffey et al.,
2006). Given that genotypes were originally selected to support
diverse physical activity patterns obligatory for human survival
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requires a high endurance capacity coupled with superior explo-
sive power, the conservation of multiple signaling networks to
meet divergent physiological demands seems to make sound
evolutionary and biological sense!
Spreading the Message: Skeletal Muscle Crosstalk
More than 50 years ago, Goldstein proposed that skeletal mus-
cle cells possessed a ‘‘humoral’’ factor that contributed to the
maintenance of glucose homeostasis during exercise (Gold-
stein, 1961). During the past decade, skeletal muscle has been
confirmed as an endocrine organ. Cytokines and other peptides
that are expressed, produced, expressed, and/or released by
muscle fibers and exert their autocrine, paracrine, or endocrine
effects are now classified as ‘‘myokines’’ (Pedersen et al.,
2003). The finding of muscle ‘‘crosstalk’’ with other organs,
including adipose tissue, liver, pancreas, bone, and the brain,
provides a framework for understanding how exercise mediates
many of its beneficial ‘‘whole-body’’ effects. Although some my-
okines exert their actions on other organs in an endocrine
fashion, many operate locally on skeletal muscle and thereby
provide a feedback loop for the muscle to regulate its own
growth and regeneration for adaptation to exercise training.
The first cytokine found to be released into the bloodstream in
response to muscle contraction was interleukin 6 (IL-6). Human
skeletal muscle is unique in that it can produce IL-6 during exer-
cise independently of tumor necrosis factor, suggesting that
muscle-derived IL-6 has a role in metabolism rather than in
inflammation. IL-6 increases both muscle and whole-body rates
of lipid oxidation (possibly though activation of AMPK) and also
contributes to hepatic glucose production during exercise.
Contracting muscle fibers produce many circulating factors.
The current list of potential myokines includes but is not limited
to IL-8, IL-15, decorin, follistatin-like 1, fibroblast growth fac-
tor-21 (FGF21), irisin, chemokine CXC motif ligand-1 (CXCL-1)
also known as KC (keratinocyte-derived chemokine), and mete-
orin-like (Metrnl) (Bostro¨m et al., 2012; Rao et al., 2014; Pedersen
et al., 2012; Wrann et al., 2013). A small-molecule myokine,
b-aminoisobutyric acid (BAIBA), with effects on adipose tissue
and liver, has also been described (Roberts et al., 2014). Most
recently, exercise-induced alterations in kynureninemetabolism,
mediated via increased skeletal muscle PGC-1a1 expression, in-
crease resilience to stress-induced depression in mice (Agudelo
et al., 2014). Although the potential therapeutic benefits of mus-
cle-derived molecules for treating obesity and other inactivity-
related disorders are appealing, there is little clinical evidence
in humans to date.
Can ‘‘Exercise Mimetics’’ Ever Replace Exercise?
Many of the adaptive responses of skeletal muscle to exercise
training can be mimicked by genetic manipulation and/or drug
treatment, at least in animal models (Narkar et al., 2008). Conse-
quently, given the numerous benefits of exercise on general
health, it has been stated that ‘‘the identification of genetic
and/or orally active agents that mimic or potentiate the effects
of endurance exercise is a longstanding albeit elusive medical
goal’’ (Narkar et al., 2008). Recognizing the proven benefits of
exercise training on health outcomes and the trend toward
increasing inactivity at the population level, efforts are underway
to discover orally active compounds that mimic or potentiate
the effects of exercise training, so-called ‘‘exercise mimetics.’’746 Cell 159, November 6, 2014 ª2014 Elsevier Inc.Although the concept of taking a pill to obtain the benefits of
exercise without actually expending any energy has mass ap-
peal for a large majority of sedentary individuals, such an
approach is likely to fail. Exercise training provokes widespread
perturbations in numerous cells, tissues, and organ, conferring
multiple health-promoting benefits, and it is the multiplicity and
complexity of these responses and adaptations that make it
highly improbable that any single pharmacological approach
could ever mimic such wide-ranging effects. Though a ‘‘polypill’’
containing several agonists aimed at selected exercise-induced
targets is a possibility, such an approach is likely to be associ-
ated with multiple off-target and potential deleterious side
effects. A more achievable goal will be to identify tissue-specific
targets through a deeper understanding of the molecular path-
ways activated by exercise in various organ systems, enabling
limited aspects of the exercise response to be pharmacologi-
cally mimicked. Although such agents may be useful adjuvants
in some settings, exercise itself remains the best ‘‘polypill’’ to
improve health and wellbeing (Fiuza-Luces et al., 2013). In our
opinion, finding ways to motivate people to adopt and maintain
a physically active lifestyle will have a greater impact on individ-
ual and population health than searching for potential pharmaco-
logical treatments. If finding orally active exercise mimetics is
really a ‘‘longstanding’’ medical goal, we believe it will continue
to be elusive for reasons evident in this Review.
Beyond the Finish Line: The Next 40 Years
During the last 40 years, with the application of molecular tech-
niques to exercise biology, multiple and apparently redundant
molecular pathways engaged in many key acute and chronic
responses to exercise have been elucidated in skeletal muscle
and other tissues. Although major breakthroughs in the knowl-
edge of how exercise activates numerous cellular, molecular,
and biochemical pathways have been witnessed, direct evi-
dence linking such effects to specific health outcomes and un-
derstanding how these effects exert their benefits in different
populations remains elusive and a challenge for future research.
During the past two decades, the long-hypothesized crosstalk
between muscle and other organs via the release of substances
by the contracting muscles has been confirmed. However, in
many cases, normal responses and adaptations to both acute
exercise and chronic exercise training can be seen when one
or more key pathways are absent, are blocked with drugs, or
are otherwise attenuated. This biological redundancy indicates
that perhaps the only obligatory response to exercise is the de-
fense of homeostasis itself. Clearly a big challenge for exercise
biologists in the next 40 years will be to connect distinct
signaling cascades to defined metabolic responses and specific
changes in gene expression in skeletal muscle that occur after
exercise. This will be complicated because many of these path-
ways are not linear, but, rather, they constitute a complex
network, with a high degree of crosstalk, feedback regulation,
and transient activation. The various ‘‘omics’’ technologies
and the application of computational and systems biology ap-
proaches to problems in exercise biology should facilitate future
progress.
Future research in the field of exercise biology requires
increasingly sophisticated approaches to understand the critical
nodes of energy homeostasis and how these pathways are dis-
rupted in a number of inactivity-related disorders. Various strains
of mice have long been used to examine research questions in
exercise biology. Recent studies using the worm (Caenorhabdi-
tis elegans), fly (Drosophila melanogaster), and zebrafish (Danio
rerio) indicate that these ‘‘lower’’ metazoans also possess
unique attributes that could prove valuable in the study of meta-
bolic diseases, including the effects of exercise/muscle contrac-
tion. Detailed characterization of the known pathways regulating
lower metazoan energy metabolism may aid in identifying and
characterizing novel candidate genes for human diseases such
as obesity and type 2 diabetes mellitus, and the function of
such genes may be more amenable to streamlined characteriza-
tion in lower organisms. Although there are limitations of each
model system that need to be recognized when deploying these
organisms for target validation and, ultimately, translation into
humans, the ability to perform sophisticated and mechanistic
studies indicates that such an approach could yield transforma-
tive research outcomes in the coming decades. In the final anal-
ysis, it is the organism’s phenotype as a whole that interacts with
and adapts to the external world. The study of exercise biology
shows that the need to integrate observations from genes, mol-
ecules, and cells in a physiological context has never been
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